Rennova Health, Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was USD 1.950 million compared to USD 3.920 million a year ago. Operating loss was USD 4.183 million compared to USD 2.581 million a year ago. Net loss was USD 6.192 million compared to USD 12.265 million a year ago. Basic loss per share from continuing operations was USD 54.33 compared to USD 18.49 a year ago. For the nine months, sales was USD 5.860 million compared to USD 13.155 million a year ago. Operating loss was USD 11.283 million compared to USD 11.799 million a year ago. Net loss was USD 9.862 million compared to USD 39.132 million a year ago. Basic loss per share from continuing operations was USD 70.52 compared to USD 365.3 a year ago.